GABAAR/5-HT2AR modulator-1
GABAAR/5-HT2AR modulator-1 is an orally active and brain-penetrant GABAAR agonist and 5-HT2AR antagonist with Kd values of 0.89 and 0.78 μM. GABAAR/5-HT2AR modulator-1 blocks 5-HT-stimulated IP1 accumulation, inducing a chloride current, reduces LPS (HY-D1056)-induced increases of ROS, NO, TNF-α, IL-6, IL-1β, iNOS, and COX-2 levels. Antidepressant agent 11 dihydrochloride inhibits NF-κB pathway activation by reducing IκBα and p65 phosphorylation and blocking p65 nuclear translocation. GABAAR/5-HT2AR modulator-1 alleviates depression-like behaviors in LPS-challenged and chronic restraint stress-challenged mice, and protects hippocampal neurons against inflammation-mediated damage.
For research use only. We do not sell to patients.
- CAS No.: 3128970-09-9
- Formula: C18H31Cl2N3O3
- Molecular Weight:408.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All 5-HT Receptor Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
5-HT2A Receptor 0.78 μM (Kd) |
GABAA 0.89 μM (Kd) |
IL-1β |
IL-6 |
COX-2 |
In Vitro
GABAAR/5-HT2AR modulator-1 (Compound 4f) binds to 5-HT2AR with a Kd of 0.78 μM and binds to GABAAR with a Kd of 0.89 μM[1].
GABAAR/5-HT2AR modulator-1 binds to 5-HT1AR, 5-HT6R, 5-HT7R, and D2R with Kd values of 5.94 μM, 3.62 μM, 2.96 μM, and 8.12 μM, respectively[1].
GABAAR/5-HT2AR modulator-1 inhibits hERG potassium channels with an IC50 >30 μM, indicating low cardiotoxic risk[1].
GABAAR/5-HT2AR modulator-1 has low cytotoxicity in HEK293T, BV2, and HT22 cells, with IC50 values >100 μM[1].
GABAAR/5-HT2AR modulator-1 acts as a 5-HT2AR antagonist in transfected HEK293T cells, blocking 5-HT-stimulated IP1 accumulation with an IC50 of 0.83 μM[1].
GABAAR/5-HT2AR modulator-1 (1 μM) functions as a GABAAR agonist in HEK293T cells stably expressing human α1β3γ2 GABAAR, inducing a chloride current amplitude of -726 pA[1].
GABAAR/5-HT2AR modulator-1 (5-20 μM) concentration-dependently reduces LPS (HY-D1056)-induced ROS and NO production in BV2 microglial cells[1].
GABAAR/5-HT2AR modulator-1 (5-20 μM) concentration-dependently reduces LPS-induced mRNA expression of TNF-α, IL-6, IL-1β, iNOS, and COX-2 in BV2 microglial cells[1].
GABAAR/5-HT2AR modulator-1 (5-20 μM) concentration-dependently reduces LPS-induced secretion of TNF-α, IL-6, and IL-1β in BV2 microglial cells[1].
GABAAR/5-HT2AR modulator-1 (5-20 μM) concentration-dependently reduces LPS-induced COX-2 and iNOS protein expression in BV2 microglial cells[1].
GABAAR/5-HT2AR modulator-1 (5-20 μM) concentration-dependently inhibits LPS-induced NF-κB pathway activation in BV2 microglial cells by reducing IκBα and p65 phosphorylation and blocking p65 nuclear translocation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
| Species | Dose | Route | Cmax | Tmax | AUC0-t | AUC0-∞ | T1/2 | Bioavailability | Tmax (Plasma) | Cmax (Brain) | Tmax (Brain) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mice[1] | 1 mg/kg | i.v. | 42.2 ng/mL | 0.083 h | 24.7 ng·h/mL | 25.4 ng·h/mL | 1.15 h | / | / | / | / |
| Mice[1] | 10 mg/kg | p.o. | 35.4 ng/mL | 0.417 h | 47.9 ng·h/mL | 50 ng·h/mL | 1.86 h | 19.4 % | / | / | / |
| Mice[1] | 10 mg/kg | p.o. | / | / | / | / | / | / | 0.5 h | 5.63 ng/mL | 2 h |
In Vivo
GABAAR/5-HT2AR modulator-1 (25-50 mg/kg; p.o.) dose-dependently alleviates stress-related depression-like behaviors in chronic restraint stress-exposed male ICR mice[1].
GABAAR/5-HT2AR modulator-1 (25-50 mg/kg; p.o.) exhibits significant antidepressant-like activity at oral doses of 25 mg/kg and 50 mg/kg in naive male ICR mice and shows no overt toxicological effects on major vital organs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Depressent ICR mice (male, LPS-induced inflammation-driven depression)[1]
-
Dosage:25 mg/kg; 50 mg/kg
-
Administration:p.o.
-
Result:Restored ambulatory activity and increased central zone entries in the open field test compared to LPS-treated mice.
Significantly reduced immobility time in the tail suspension test and forced swimming test, with the 50 mg/kg dose showing the most pronounced effect.
Dose-dependently reduced hippocampal mRNA levels of TNF-α, IL-6, IL-1β, iNOS, and COX-2.
Reduced serum levels of TNF-α, IL-6, and IL-1β.
Reduced hippocampal protein levels of iNOS and COX-2.
Dose-dependently restored hippocampal structural integrity via Nissl staining, with the 50 mg/kg dose exhibiting near-normal morphology.
Dose-dependently suppressed LPS-induced microglial activation via immunofluorescence staining, with the 50 mg/kg dose displaying near-complete normalization of microglial phenotype.
Chemical Information
-
CAS No. 3128970-09-9
-
Molecular Weight 408.36
-
Formula C18H31Cl2N3O3
-
SMILES
COC1=CC=CC=C1N2CCN(CCCOC(CCCN)=O)CC2.Cl.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cytoplasmic-Nuclear Fractionated Protein Extraction
Cytoplasmic-nuclear fractionated protein extraction separates soluble cytoplasmic proteins from nuclear-enriched proteins by mild plasma-membrane permeabilization, differential centrifugation, washing of nuclei, and extraction of nuclear proteins for downstream immunoblotting or related molecular analysis. The readout is the relative abundance of a protein in cytoplasmic and nuclear fractions, commonly assessed by western blotting together with compartment markers such as tubulin or pyruvate kinase for cytoplasm and lamin, nucleoporin, hnRNP, H2AX, or Lamin B for nuclear fractions.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Primary Embryonic Hippocampal Neuron Culture
Primary embryonic hippocampal neuron culture is an in vitro method in which hippocampi from embryonic rodents are dissected, enzymatically or mechanically dissociated, plated on adhesive substrates, and maintained in defined neuronal medium or in low-density sandwich/co-culture formats to support neuronal attachment, neurite extension, polarity formation, dendritic arborization, and synapse formation. The main readouts are cell survival, neuronal purity, neurite outgrowth, axon-dendrite polarization, synaptic marker development, and functional neuronal activity, assessed by phase-contrast microscopy, immunocytochemistry for neuronal/glial markers, live imaging, or electrophysiology depending on the downstream experiment.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- GABAAR/5-HT2AR modulator-1
- 3128970-09-9
- GABA Receptor
- 5-HT Receptor
- Reactive Oxygen Species (ROS)
- TNF Receptor
- Interleukin Related
- COX
- NF-κB
- IKK
- NO Synthase
- hippocampal neurons
- HT22 cells
- GABAAR
- NF-κB pathway
- neuroinflammation
- ICR mice
- 5-HT2AR
- HEK293T cells
- microglial GABAARs
- BV2 microglial cells
- Inhibitor
- inhibitor
- inhibit